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Efficient	  and	  scalable	  synthesis	  of	  α,α-­‐disubstituted	  β-­‐amino	  
amides	  
Marianne	  Hagensen	  Paulsen,a	  Magnus	  Engqvistb,	  Dominik	  Ausbachera,	  Morten	  Bøhmer	  Strøma	  
and	  Annette	  Bayer*,b	  
A	  practical	  and	  efficient	  methodology	  for	  the	  preparation	  of	  2-­‐aminoethyl	  α,α-­‐disubstituted	  β-­‐amino	  amides	  in	  three	  steps	  
from	  methyl	  2-­‐cyano	  acetate	  has	  been	  developed.	  The	  key	  step	  in	  the	  synthesis	  was	  the	  chemoselective	  reduction	  of	  the	  
nitrile	   group	   in	   presence	   of	   an	   amide	   and	   aryl	   halide	   functionalities.	   Reduction	  with	   Raney	  Nickel	   catalyst,	   either	  with	  
molecular	  hydrogen	  (8-­‐10	  bar)	  or	  under	  transferhydrogenation	  conditions,	  nessecitated	  in	  situ	  protection	  of	  the	  resulting	  
amines	  with	  Boc2O,	  whereas	  aryl	  bromide	  containing	  nitriles	  could	  be	  chemoselectively	  reduced	  with	  ZnCl2/NaBH4	  without	  
debromination.	   The	   developed	   protocol	   involved	   only	   one	   chromatographic	   purification	   step	   and	   can	   be	   performed	   at	  
gram	  scale.	  	  
Introduction	  
β-­‐Amino	  acids	  are	  important	  building	  blocks	  that	  are	  found	  as	  
components	   of	   natural	   products	   such	   as	   taxol1	   and	  
microcystin2	  and	  in	  peptidomimetics3-­‐5	  to	  imitate	  the	  function	  
of	  bioactive	  peptides.	  Due	  to	  the	  additional	  methylene	  group,	  
proteases	  such	  as	  trypsin	  and	  α-­‐chymotrypsin6,	  7	  are	  unable	  to	  
recognize	  β-­‐amino	  acids.	  Thus,	  incorporation	  of	  β-­‐amino	  acids	  
into	   peptides	   is	   a	   known	   strategy	   to	   increase	   proteolytic	  
stability.4,	  8-­‐10	  Peptidomimetics	  consisting	  of	  β-­‐amino	  acids	  can	  
also	   form	   unique	   secondary	   structures11,	   12	   due	   to	   increased	  
rotational	   possibilities	   that	   are	   useful	   for	   improving	   the	  
biological	  activity	  of	  peptides.10,	  13	  	  
Naturally	   occurring	   antimicrobial	   peptides	   (AMP)	   have	  
attracted	  much	  attention	  due	  to	  their	  potential	  as	  a	  new	  class	  
of	  antibiotics	  and	  anticancer	  agents.14	  Both,	  antimicrobial	  and	  
chemotherapeutic	   agents	   with	   a	   novel	   mechanism	   of	   action	  
are	   strongly	   needed	   to	   fight	   the	   emergence	   of	   therapy	  
resistant	  tumours	  and	  multi-­‐drug	  resistant	  bacterial	  infections.	  
Our	  group	  has	  reported	  a	  series	  of	  antimicrobial	  and	  cytotoxic	  
α,α-­‐disubstituted	   β-­‐amino	   acid	   derivatives.	   These	   derivatives	  
have	   an	   amphipathic	   structure	   consisting	   of	   two	   cationic	  
groups	  and	  two	  lipophilic	  side-­‐chains	  previously	  described	  as	  a	  
pharmacophore	  model	   for	   small	   cationic	  AMPs.15-­‐17	  However,	  
we	   have	   observed	   that	   the	   aromatic	   side-­‐chains	   of	   the	   α,α-­‐
disubstituted	   β-­‐amino	   acid	   derivatives	   are	   subjected	   to	  
metabolism	   by	   liver	   microsomes,	   which	   can	   complicate	   drug	  
development.18	   Aromatic	   systems	   can	   be	   protected	   against	  
such	  metabolic	  transformations	  by	  the	  introduction	  of	  electron	  
withdrawing	  groups	  such	  as	  fluoro	  or	  bromo	  substituents.	  This	  
spurred	   our	   interest	   in	   finding	   an	   efficient	   and	   scalable	  
synthesis	   allowing	   for	   the	   preparation	   of	   halogenated	  
analogues	   of	   α,α-­‐disubstituted	   β-­‐amino	   amides	   with	   the	  
general	  structure	  shown	  in	  Fig.	  1.	  
A	   number	   of	   methods	   for	   the	   preparation	   of	   α,α-­‐
disubstituted	   β-­‐amino	   acids	   and	   derivatives	   have	   been	  
reported	  (Scheme	  1).	  Dialkylation	  of	  cyano	  acetate	  alkyl	  ester	  
followed	  by	  nitrile	  reduction	  and	  ester	  hydrolysis	  (A)	  was	  first	  
described	  by	  Cronin	  and	  coworkers6	  and	  has	  later	  been	  applied	  
by	   us16,	   17	   and	  others.19	   Reddy	  et	   al.	   published	   an	   interesting	  
approach	  based	  on	  palladium-­‐catalysed	  directed	  C-­‐H	  activation	  
of	   cyanoacetamides	   followed	   by	   arylation	   (B1)	   and	   nitrile	  
reduction	  with	   Pd/C	   (B2).
20	   Capone	   et	   al.	   reported	   the	   direct	  
alkylation	  of	  protected	  β-­‐alanine	  using	  KHMDS	  as	  base	   (C)	   21,	  
while	   Lin	   et	   al.	   reported	   a	   related	   approach	   based	   on	   the	  
alkylation	  and	  reduction	  of	  a	  β-­‐alanine	  nickel(II)	  complex	  (D).22	  
Alkylated	   β-­‐alanines	   were	   obtained	   after	   reduction	   of	   the	  
nickel	   complexes	   by	   NaBH4	   or	   Pd/C.	   Strategies	   based	   on	   the	  
introduction	   of	   the	   amine	   on	   an	   alkylated	   precursor	   include	  
the	   Mitsunobu	   reaction	   of	   3-­‐hydroxypropionate	   and	  
phthalimide	   described	   by	   Ducry	   and	   coworkers	   (E),23	   and	  	  
Mannich	  or	  Vilsmeier-­‐Haack	  type	  reactions	  between	  silyl	  enol	  
ethers	  of	  2,2-­‐disubstituted	  acetic	  acids	  or	  esters	  and	   iminium	  
salts	  (F)	  developed	  by	  the	  group	  of	  Karoyan24	  and	  Bélanger25,	  	  
	  
Fig.	   1.	   General	   structure	   of	   desired	   α,α-­‐disubstituted	   β-­‐amino	   acid	   derivatives	  
containing	   two	   halogenated	   aromatic	   side	   chains	   and	   a	   2-­‐aminoethyl	   C-­‐terminus.
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Scheme	  1	  Reported	  approaches	  to	  α,α-­‐disubstituted	  β-­‐amino	  acids	  and	  derivatives.	  
respectively.	  However,	  these	  reported	  protocols	  require	  either	  
long	  reaction	  sequences,	  harsh	  reaction	  conditions	  or	  are	  not	  
compatible	   with	   aryl	   bromides	   due	   to	   the	   use	   of	   transition	  
metal	  catalysts,	  which	  are	  prone	  to	  lead	  to	  dehalogenation.	  
Here	  we	  present	   an	  efficient	   and	  easily	   scalable	   synthesis	  
of	   2-­‐aminoethyl	   amides	   of	   α,α-­‐disubstituted	   β-­‐amino	   acids.	  
Additionally,	   a	   bromide	   compatible	   variant	  was	   developed	   to	  
allow	   for	   the	   preparation	   of	   aryl	   bromide	   substituted	  
derivatives.	  
Results	  and	  discussion	  
Our	   group	   has	   previously	   prepared	   analogues	   of	   the	   target	  
compounds.	   In	   the	   reported	   synthesis16,	   17	   (Scheme	   2A),	   the	  
methyl	  cyano	  acetate	  was	  alkylated	  with	  a	  variety	  of	  alkyl	  and	  
aryl	  halides.	  This	  was	  followed	  by	  reduction	  of	  the	  nitrile	  group	  
with	  Raney	  nickel	  to	  provide	  the	  alkylated	  β-­‐amino	  ester.	  After	  
Boc-­‐protection	  of	  the	  amine,	  the	  methyl	  ester	  was	  hydrolysed	  
to	   the	   corresponding	   carboxylic	   acid.	   After	   activation	   of	   the	  
acids	   with	   fluoro-­‐N,N,Nʹ′,Nʹ′-­‐tetramethylformamidinium	   hexa-­‐
fluorophosphate	   (TFFH),	   coupling	   with	   the	   desired	   amine	  
provided	   the	   disubstituted	   β2,2-­‐amino	   amides.16	   Initial	  
experiments	   revealed	   that	   this	   protocol	   consisted	   of	   several	  
work-­‐intensive	  steps	  and	  was	  not	  compatible	  with	  brominated	  
substrates.	   Partial	   or	   complete	   debromination	   was	   observed	  
during	  the	  nitrile	   reduction	  step	  with	  Raney	  nickel,	   leading	  to	  
product	  mixtures	   that	  were	  difficult	   to	   separate	  or	  unwanted	  
products.	   Consequently,	   we	   developed	   a	   more	   efficient	  
synthesis	   as	   shown	   in	   Scheme	  2B.	  Methyl	   cyano	   acetate	  was	  
dialkylated,	   followed	   by	   aminolysis	   and	   nitrile	   reduction,	   as	  
described	   below.	   This	   strategy	   circumvented	   the	   amide	  
coupling	  with	   TFFH	   and	   the	   protection/deprotection	   steps	   of	  
the	   previous	  method	   and	   thereby	   significantly	   shortened	   the	  
protocol.	  A	  key	  challenge	  was,	  however,	  to	  find	  a	  method	  for	  a	  
chemoselective	  nitrile	  reduction.	  
The	  dialkylation	  of	   cyano	  acetate	  esters	   is	  well	   known.26-­‐30	   In	  
the	  course	  of	  our	  work,	  several	  of	  the	  reported	  protocols	  were	  
investigated.	   A	   modification	   of	   Oedigers	   method30,	   the	   1,8-­‐
diazabicyclo[5.4.0]undec-­‐7-­‐ene	  (DBU)	  mediated	  dialkylation	  of	  
methyl	  cyano	  acetate	  (2)	  in	  CH2Cl2,	  was	  found	  to	  be	  a	  fast	  and	  
convenient	  procedure	  providing	  the	  dialkylated	  cyano	  acetates	  
(3	  a-­‐j)	   in	  almost	  quantitative	  yields	   (>	  95%	   for	  all	   derivatives,	  
except	  3g)	   (Scheme	  3).	  The	  reaction	   times	  were	  short	  and	  10	  
min	  proved	  to	  be	  sufficient	  on	  a	  1	  mmol	  scale.	  
	  
Scheme	  2	  A.	  Previous	  reported	  method	  for	  synthesis	  of	  α,α-­‐disubstituted	  β-­‐amino	  amides;	  B.	  improved	  method	  described	  in	  this	  work.	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The	   reaction	   was	   easily	   scaled	   up	   to	   a	   50	   mmol	   scale.	   The	  
crude	  products	  were	  recrystallized	  in	  MeOH.	  
A	   common	  method	   for	   the	   formation	   of	   amide	   bonds	   is	   the	  
peptide	  coupling	  of	  amines	  with	  activated	  carboxylic	  acids	  like	  
acid	  chlorides	  or	  in	  situ	  activated	  carboxylic	  acids.	  A	  variety	  of	  
attempts	  to	  couple	   in	  situ	  activated	  carboxylic	  acids,	  obtained	  
after	  hydrolysis	  of	  3,	  with	  N-­‐Boc	  ethylene	  diamine	   in	  analogy	  
to	   the	   previously	   reported	   method17	   gave	   low	   yields	   and	   a	  
significant	   amount	   of	   by-­‐products	   thus	   requiring	  
chromatographic	   purification.	   Therefore,	   aminolysis	   of	   the	  
methyl	   esters	   was	   investigated	   as	   a	   more	   convenient	   and	  
economic	  procedure	  (Table	  1).	  The	  dialkylated	  methyl	  esters	  (3	  
a-­‐j)	  were	  dissolved	   in	  ethylene	  diamine	  as	  solvent	  and	  stirred	  
until	  TLC	  indicated	  completion	  (0.5–24	  h).	  Precipitation	  of	  the	  
products	   by	   addition	   of	   water	   gave	   the	   corresponding	   2-­‐
aminoethyl	   cyano	   amides	   4a-­‐j	   in	   good	   yields	   (72–98%)	   and	  
purity	  (>	  95%	  as	  determined	  by	  analytical	  HPLC)	  (Table	  1).	  The	  
reaction	   was	   carried	   out	   up	   to	   a	   50	   mmol	   scale.	   Other	  
protocols	   for	   assisted	   aminolysis31,	   32	   were	   examined	   but	   did	  
not	  provide	  significant	  improvement.	  
Initially,	   the	   chemoselective	   reductions	   of	   nitriles	   in	  
presence	   of	   amides	   with	   Raney	   nickel	   were	   investigated	   for	  
the	  cyano	  amides	  4a—j.	   In	  general,	   the	  reductions	  were	  slow	  
(1	   bar,	   45	   °C,	   5	   days)	   and	   low	   yields	  were	   obtained	   (<	   30%).	  
Not	  surprisingly,	   the	  reduction	  of	  the	  aryl	  bromide	  containing	  
nitriles	   4a	   and	   4b	   resulted	   in	   substantial	   debromination.	  We	  
hypothesise	   that	   the	   inefficient	   reduction	   with	   Raney	   nickel	  
might	   relate	   to	   coordination	  by	   the	  amine	   functionalities	  and	  
formation	   of	   byproducts.	   Therefore,	   reductions	   were	  
performed	   in	   presence	   of	   Boc2O	   to	   affect	   simultaneous	  
reduction	  and	  protection	  of	   the	  amine	  groups.	  By	  addition	  of	  
Boc2O	   (4	   eq.),	   reductions	   at	   8-­‐10	   bar	   in	   MeOH	   (Table	   2,	  
Method	  A)	  gave	  full	  conversion	  within	  18	  h	  determined	  by	  MS	  
and	  NMR	  of	  the	  crude.	  Deprotection	  (1.33	  M	  HCl	  in	  dioxane)	  of	  
the	   crude	   provided	   the	   target	   amino	   amides	   1c—j	   (Table	   2,	  
entries	   4-­‐7,	   9,	   10	   and	   12).	   Yields	   were	   good	   (>	   70%)	   when	  
purification	  by	  precipitation	  was	  possible	  (Table	  2,	  entries	  4,	  5,	  
	  
Scheme	  3	  Dialkylation	  of	  methyl	  2-­‐cyanoacetate	  2.	  
9	   and	   12).	   When	   chromatographic	   purification	   (C18	   reverse	  
phase	   flash	   chromatography)	   was	   necessary	   the	   yields	  
dropped	  (25–52%)	  for	  most	  of	  the	  products	  (Table	  2,	  entries	  4,	  
6,	  7,	  9,	  10	  and	  12).	  The	  reductions	  were	  routinely	  carried	  out	  
at	  a	  0.2-­‐0.6	  mmol	  scale.	  To	  test	  the	  scalability	  of	  method	  A,	  a	  
reduction	  of	  2.5	  mmol	  of	  4j	  (1	  g)	  was	  carried	  out.	  The	  reaction	  
at	  this	  scale	  did	  not	  result	  in	  the	  desired	  conversion	  within	  18h	  
reaction	  time.	  
Additionally,	  reduction	  of	  the	  nitrile	  group	  with	  a	  modified	  
protocol	   at	   1	   bar	   using	   transfer	   hydrogenation	   conditions	  
(Method	  B)	  with	  ammonium	  formate	  as	  hydrogen	  source	  was	  
investigated	  (Table	  2,	  entries	  8,	  11,	  13	  and	  14).	  For	  substances	  
4h	  and	  4j	  good	  yields	  (62%	  of	  4h	  and	  80%	  of	  4j)	  were	  obtained	  
within	  48	  h	  (entries	  11	  and	  14),	  while	  other	  substrates	  (4f	  and	  
4i)	   showed	   low	   conversion	   (<	   30%)	   (entries	   8	   and	   13).	   A	  
reaction	  under	   transfer	   hydrogenation	   conditions	   (method	  B)	  
was	   performed	   at	   a	   2.6	   mmol	   scale	   with	   good	   results	   (80%	  
yield).	  
An	   important	   aim	   of	   this	   study	   was	   the	   preparation	   of	  
halogen-­‐containing	  analogues	  of	  1.	  As	  expected,	  the	  modified	  
Raney	   nickel	   reduction	   did	   not	   prevent	   the	   unwanted	  
debromination.	   In	   the	   reduction	   of	   4a	   by	   Raney	   nickel	   with	  
ammonium	  formate	  at	  1	  bar	  in	  presence	  of	  Boc2O	  (Method	  B),	  
substantial	   debromination	   was	   observed	   already	   after	   1h	  
reaction	   time	   (Table	   2,	   entry	   1).	   Caddick	   and	   coworkers	  
described	  selective	  reductions	  of	  nitriles	   in	  presence	  of	  either	  
amides	  or	  aryl	  bromides	  employing	  catalytic	  nickel(II)	  chloride	  
with	   excess	   sodium	   borohydride.33	   In	   our	   case,	   this	   protocol	  
resulted	  in	  dehalogenation.	  Dehalogenation	  also	  occurred	  with	  
CoCl2/NaBH4.
19,	   34,	   35	   Finally,	  we	   achieved	   the	   desired	   chemo-­‐
selectivity	  with	  a	  system	  of	  ZnCl2/NaBH4	  as	  reducing	  agent.
36	  





Rxn.	  time	  (h)	   Yield	  (%)	  
1	   3a	   2	   97	  
2	   3b	   1	   94	  
3	   3c	   5	   92	  
4	   3d	   3	   96	  
5	   3e	   0.5	   98	  
6	   3f	   6	   76	  
7	   3g	   2	   85	  
8	   3h	   1	   92	  
9	   3i	   24a	   72b	  
10	   3j	   24	   82c	  
a.	  The	  starting	  material	  was	  poorly	  soluble;	  b.10	  g	  scale;	  c.	  23	  g	  scale	  
Paper	   Organic	  &	  Biomolecular	  Chemistry	  
4 	  |	  Org.	  Biomol.Chem.,	  2016,	  00,	  1-­‐3	   This	  journal	  is	  ©	  The	  Royal	  Society	  of	  Chemistry	  20xx	  
Please do not adjust margins 
Please do not adjust margins 
Reduction	   of	   nitriles	   4a	   and	   4b	   with	   ZnCl2/NaBH4	   gave	   the	  
corresponding	   amines	   1a	   in	   75%	   and	   1b	   in	   80%	   yield	   after	  
decomplexation	  of	  any	  amine-­‐boron	  complexes	  by	  boiling	  in	  6	  
M	  aqueous	  HCl	  and	  chromatographic	  purification	  (C18	  RP	  flash	  
chromatography).	  Interestingly,	  no	  significant	  hydrolysis	  of	  the	  
amides	  1a	   and	  1b	  was	  observed	  during	   the	   acidic	   treatment,	  
however	   prolonged	   acidic	   treatment	   resulted	   in	  
decarboxylative	  loss	  of	  the	  amide	  functionality.	  
Conclusions	  
In	   summary,	   we	   have	   describe	   a	   convenient	   and	   robust	  
approach	   to	   α,α-­‐dialkylated	   β-­‐amino	   amides	   comprising	   of	   a	  
dialkylation	   with	   DBU,	   followed	   by	   aminolysis	   and	  
chemoselective	   reduction	   of	   the	   nitrile	   group.	   A	   nitrile	  
reduction	   method	   that	   tolerates	   the	   presence	   of	   bromoaryl	  
substituents	   was	   developed.	   Only	   one	   chromatographic	  
purification	  was	  needed	   to	   yield	  >	  95%	  pure	   compounds	   in	   a	  
three	  step	  procedure	  with	  an	  overall	  yield	  of	  21–84%.	  
Experimental	  section	  
Materials	  and	  methods	  
All	   reagents	   and	   solvents	   were	   purchased	   from	   commercial	  
sources	   and	   used	   as	   supplied	   unless	   otherwise	   stated.	  
Anhydrous	   THF	  was	   prepared	   by	   storage	   over	   4	   Å	  molecular	  
sieves.	   Raney	   nickel	   was	   bought	   from	   Sigma	   Aldrich	   (CAS	  
no.	  7440-­‐02-­‐0,	   2800,	   slurry,	   in	   H2O,	   active	   catalyst).	   The	  
hydrogenations	  with	  Raney	  nickel	  at	  higher	  pressure	  (810	  bar)	  
were	   carried	   out	   on	   a	   Parr	   Instrument,	   Series	   4590	   Micro	  
Stirred	   reactor,	   50	   mL,	   attached	   to	   a	   Parr	   4843	   Modular	  
Controller.	   Reactions	   were	   monitored	   by	   thin-­‐layer	  
chromatography	   (TLC)	  with	  Merck	  pre-­‐coated	   silica	  gel	  plates	  
(60	   F254).	   Visualization	  was	   accomplished	  with	   either	  UV	   light	  
or	   by	   immersion	   in	   potassium	   permanganate	   or	  
phosphomolybdic	  acid	   (PMA)	  followed	  by	   light	  heating	  with	  a	  
heating	   gun.	   Purification	   of	   reactions	   was	   carried	   out	   by	  
chromatography	   using	   a	   RP	   C18	   column	   preloaded	   on	   a	  
Samplet®	   cartridge	   belonging	   to	   a	   Biotage	   SP-­‐1.	   Analytical	  
HPLC	  was	   carried	   out	   on	   a	  Waters	   2695	   Separations	  Module	  
equipped	   with	   an	   XBridge™	   C18	   5	   µm,	   4.6	   mm	   x	   250	   mm	  
column	  and	  analysed	  at	  wavelengths	  214	  and	  254	  nm	  with	  a	  
Waters	   996	   PDA	  detector	   spanning	   from	  wavelengths	   210	   to	  
310	   nm.	   The	   compounds	   were	   eluated	   with	   water	   and	  
acetonitrile,	  both	  containing	  0.1%	  TFA.	  The	  gradient	  started	  at	  
10%	   acetonitrile,	   3	   minutes	   isocratic	   gradient,	   followed	   by	   a	  
linear	   increase	  to	  90	  %	  acetonitrile	  over	  17	  minutes,	  followed	  
by	  an	  8	  min	  acetonitrile	  wash	  and	  then	  10	  min	  equilibration	  to	  
the	   starting	   gradient.	   The	   flow	   rate	   was	   1	   ml/min.	   NMR	  
spectra	   were	   obtained	   on	   a	   400	   MHz	   Bruker	   Avance	   III	   HD	  
equipped	  with	  a	  5	  mm	  SmartProbe	  BB/1H	  (BB=19F,	  31P-­‐15N).	  
Data	  are	  represented	  as	  follows:	  chemical	  shift,	  multiplicity	   (s	  
=	  singlet,	  d	  =	  doublet,	  t	  =	  triplet,	  q	  =	  quartet,	  p	  =	  pentet,	  m	  =	  
multiplet),	  coupling	  constant	   (J,	  Hz)	  and	   integration.	  Chemical	  
shifts	   (δ)	  are	   reported	   in	  ppm	  relative	   to	   the	   residual	   solvent	  
peak	  (CDCl3:	  δH	  7.26	  and	  δC	  77.16;	  Methanol-­‐d4:	  δH	  3.31	  and	  δC	  






Methoda	   Rxn.	  time	  (h)	   Yield	  (%)	  
1	  
4a	  
B	   1	   ndb	  
2	   C	   1.5	   75d	  
3	   4b	   C	   1.5	   80d	  
4	   4c	   A	   18	   80c	  /	  25d	  
5	   4d	   A	   18	   90c	  
6	   4e	   A	   18	   40d	  
7	  
4f	  
A	   18	   50
b	  
8	   B	   48	   30b	  
9	   4g	   A	   18	   75c	  /	  50d	  
10	  
4h	  
A	   18	   52
d	  
11	   B	   48	   62d	  
12	  
4i	  
A	   20	   72
c	  /	  35d	  
13	   B	   24	   27d	  
14	   4j	   B	   48	   80d	  
a:	  Method	  A:	   i.	  Raney	  Ni,	  H2	   (8–10	  bar),	  Boc2O	   (approx.	  4	  eq.),	  MeOH,	  45	  °C	   ii.	  
1.33M	  HCl	  in	  dioxane;	  Method	  B:	  i.	  Raney	  Ni,	  ammonium	  formate	  (4	  eq.),	  Boc2O	  
(4	  eq.),	  EtOAc	  or	  MeOH,	  45	  °C	  ii.	  1.33M	  HCl	  in	  dioxane;	  Method	  C:	  ZnCl2/NaBH4;	  
b.	  Dehalogenated	  product;	  c.	   Isolated	  yield	  after	  crystallisation;	  d.	   Isolated	  yield	  
after	  chromatographic	  purification.	  
49.00).	  Positive	  ion	  electrospray	  ionization	  mass	  spectrometry	  
was	   conducted	   on	   a	   Thermo	   electron	   LTQ	   Orbitrap	   XL	  
spectrometer.	  
General	  procedure	  for	  dialkylation	  of	  methyl	  cyanoacetate	  2	  
Methyl	  cyanoacetate	  2	  was	  dissolved	  in	  CH2Cl2	  (approx.	  0.1	  M,	  
prefiltered	  through	  K2CO3),	  cooled	  to	  0	  °C,	  added	  DBU	  (2	  eq.)	  
and	   stirred	   for	   2	   min.	   The	   alkyl	   halide	   (2	   eq.)	   was	   added	   in	  
small	  portions	   to	  avoid	   increase	   in	   temperature.	  The	  reaction	  
was	   left	   to	   stir	   at	   RT	   until	   completion.	   The	   reaction	   was	  
monitored	  on	  TLC	   (1:4	   EtOAc/toluene).	  After	   completion,	   the	  
reaction	  was	  quenched	  with	  water	  and	  extracted	  with	  EtOAc.	  
The	  organic	  phase	  was	  washed	  with	  water	  (3	  times)	  and	  brine,	  
dried	   over	   Na2SO4,	   filtered	   and	   evaporated	   to	   dryness.	   To	  
remove	   residual	   EtOAc,	   chloroform	   was	   added	   and	   re-­‐
evaporated.	   If	  necessary,	  MeOH	  was	  added	  to	  precipitate	  the	  
crude.	  The	  resulting	  solid	  was	  recrystallized	  in	  MeOH.	  
	  
Methyl	   3-­‐(2-­‐bromophenyl)-­‐2-­‐[(2-­‐bromophenyl)methyl]-­‐2-­‐
cyanopropionate	  (3a).	  Methyl	  cyanoacetate	  2	   (34	  mmol,	  2.99	  
mL),	   DBU	   (70.3	  mmol,	   10.5	  mL)	   and	   2-­‐bromobenzyl	   bromide	  
(68	  mmol,	  16.94	  g)	   gave	   the	   title	   compound	   (13.9	  g,	   94%)	  as	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white	   crystals.	   1H	  NMR	   (400	  MHz,	  CDCl3):	  δ	  7.60	   (dd,	   J	   =	   8.0,	  
1.4,	  2H),	  7.42	   (dd,	   J	  =	  7.7,	  1.7,	  2H),	  7.30	   (td,	   J	  =	  7.5,	  1.4,	  2H),	  
7.16	  (td,	  J	  =	  7.7,	  1.7,	  2H),	  3.75	  (s,	  3H),	  3.57	  (dAB,	  J	  =	  14.2,	  2H),	  
3.52	   (dAB,	   J	   =	   14.2,	   2H).	  
13C	   NMR	   (101	  MHz,	   CDCl3):	   δ	   168.5,	  
134.0,	   133.3,	   131.3,	   129.5,	   127.7,	   125.9,	   117.8,	   53.8,	   51.1,	  
40.9.	   HRMS	   (ESI)	   m/z:	   [M+Na]+	   Calculated	   for	  
C18H15
79Br2NNaO2 457.9359;	  Found:	  457.9365.	  	  
Methyl	   2-­‐cyano-­‐3-­‐(3,5-­‐dibromophenyl)-­‐2-­‐[(3,5-­‐
dibromophenyl)	   methyl]propionate	   (3b).	   Methyl	  
cyanoacetate	  2	   (7.39	  mmol,	   0.65	  mL),	   DBU	   (17.1	  mmol,	   2.55	  
mL)	  and	  3,5-­‐dibromobenzyl	  bromide	  (15.2	  mmol,	  5.00	  g)	  gave	  
the	   title	   compound	   (4.90	   g,	   99%)	   as	   white	   crystals.	   1H	   NMR	  
(400	  MHz,	  CDCl3):	  δ	  7.64	   (t,	   J	  =	  1.8,	  2H),	  7.36	   (d,	   J	  =	  1.8,	  4H),	  
3.67	  (s,	  3H),	  3.24	  (dAB,	  J	  =	  13.5,	  2H),	  2.99	  (dAB,	  J	  =	  13.5,	  2H).	  
13C	  
NMR	   (101	   MHz,	   CDCl3):	   δ	   168.0,	   137.4,	   134.2,	   131.8,	   123.4,	  
117.2,	   53.9,	   52.6,	   42.2. HRMS	   (ESI)	   m/z:	   [M+Na]+	   Calculated	  
for	  C18H13
79Br4NNaO2 613.7571 Found:	  613.	  7563	  
2-­‐fluorophenyl)-­‐2-­‐[(2-­‐fluorophenyl)methyl]propionate	   (3c). 
Methyl	  cyanoacetate	  2	  (8.41	  mmol,	  0.74	  mL),	  DBU	  (16.8	  mmol,	  
2.51	   mL)	   and	   2-­‐fluorobenzyl	   bromide	   (16.8	   mmol,	   2.03	   mL)	  
gave	   the	   title	   compound	   (2.62	   g,	   98%)	   as	   white	   crystals.	   1H	  
NMR	  (400	  MHz,	  CDCl3):	  δ	  7.36-­‐7.27	  (m,	  4H),	  7.15-­‐7.05	  (m,	  4H),	  
3.69	  (s,	  3H),	  3.39	  (dAB,	  J	  =	  13.8,	  2H),	  3.29	  (dAB,	  J	  =	  13.9,	  2H).	  
13C	  
NMR	  (101	  MHz,	  CDCl3):	  δ	  168.4,	  161.4	  (d,	  J	  =	  247.2),	  132.1	  (d,	  J	  
=	  3.7),	  130.1	  (d,	  J	  =	  8.4),	  124.5	  (d,	  J	  =	  3.6),	  121.4	  (d,	  J	  =	  15.3),	  
117.9,	   115.7	   (d,	   J	   =	   22.4),	   53.6,	   51.6,	   35.6	   (d,	   J	   =	   2.2).	   HRMS	  
(ESI)	   m/z:	   [M+Na]+	   Calculated	   for	   C18H15F2NNaO2	   338.0963;	  
Found:	  338.	  0951 
Methyl	   2-­‐cyano-­‐3-­‐(2,6-­‐difluorophenyl)-­‐2-­‐[(2,6-­‐
difluorophenyl)methyl]propionate	   (3d).	  Methyl	   cyanoacetate	  
2	   (8.4	   mmol,	   0.74	   mL),	   DBU	   (17	   mmol,	   2.51	   mL)	   and	   2,6-­‐
difluorobenzyl	   bromide	   (17	   mmol,	   3.476	   g)	   gave	   the	   title	  
compound	  (2.88	  g,	  97%)	  as	  pale	  yellow	  crystals.	  1H	  NMR	  (400	  
MHz,	  CDCl3):	  δ	  7.29	  (ddd,	  J	  =	  8.4,	  6.6,	  1.9,	  2H),	  6.93	  (br	  dd,	  J	  =	  
7.9,	  4H),	  3.80	  (s,	  3H),	  3.45	  (dAB,	  J	  =	  14.1,	  2H),	  3.40	  (dAB,	  J	  =	  14.1,	  
2H).	  13C	  NMR	  (101	  MHz,	  CDCl3):	  δ	  168.2,	  161.9	  (dd,	  249.4,	  7.6),	  
130.3	   (t,	   J	  =	   10.5),	  116.9,	  112.0-­‐111.4	   (m),	  110.6	   (t,	   J	  =	   19.6),	  
54.0,	   50.0,	   30.0.	   HRMS	   (ESI)	   m/z:	   [M+Na]+	   Calculated	   for	  
C18H13F4NNaO2	  374.0774;	  Found:	  374.0772	  
Methyl	   2-­‐cyano-­‐3-­‐(3,5-­‐difluorophenyl)-­‐2-­‐[(3,5-­‐
difluorophenyl)methyl]propionate	   (3e).	  Methyl	   cyanoacetate	  
2	   (8.87	   mmol,	   0.78	   mL),	   DBU	   (18	   mmol,	   2.76	   g)	   and	   3,5-­‐
difluorobenzyl	   bromide	   (17	   mmol,	   2.25	   mL)	   gave	   the	   title	  
compound	  (3.05	  g,	  98%)	  as	  white	  crystals.	  1H	  NMR	  (400	  MHz,	  
CDCl3):	   δ	   6.85-­‐6.76	   (m,	   6H),	   3.64	   (s,	   3H),	   3.30	   (dAB,	   J	   =	   13.5,	  
2H),	   3.06	   (dAB,	   J	   =	   13.5,	   2H).	  
13C	   NMR	   (101	   MHz,	   CDCl3):	   δ	  
168.0,	   163.1	   (dd,	   J	   =	   249.7,	   12.9),	   137.2	   (t,	   J	   =	   9.1),	   117.6,	  
113.2-­‐113.0	   (m),	   104.1,	   (t,	   J	   =	   25.2),	   53.8,	   52.6,	   42.8.	   HRMS	  
(ESI)	   m/z:	   [M+Na]+	   Calculated	   for	   C18H13F4NNaO2	   374.0774;	  
Found:	  374.0763 
Methyl	   2-­‐cyano-­‐3-­‐[2-­‐(trifluoromethyl)phenyl]-­‐2-­‐{[2-­‐
(trifluoromethyl)phenyl]methyl}	   propionate	   (3f).	   Methyl	  
cyanoacetate	  2	  (4.94	  mmol,	  0.44	  mL),	  DBU	  (10.8	  mmol,	  1.65	  g)	  
and	   2-­‐(trifluoromethyl)benzyl	   bromide	   (9.96	   mmol,	   2.38	   g)	  
gave	  the	  title	  compound	  (2.1	  g,	  98%)	  as	  white	  crystals.	  1H	  NMR	  
(400	  MHz,	  CDCl3):	  δ	  7.70	  (d,	  J	  =	  8,	  2H),	  7.58-­‐7.51	  (m,	  4H),	  7.42	  
(t,	  J	  =	  7.5,	  2H),	  3.76	  (s,	  3H),	  3.62	  (dAB,	  J	  =	  14.9,	  2H),	  3.42	  (dAB,	  J	  
=	  14.9,	  2H).	  13C	  NMR	  (101	  MHz,	  CDCl3):	  δ	  169.0,	  133.0,	  132.1,	  
130.9,	  129.7	  (q,	  J	  =	  29.6),	  128.2,	  126.7	  (q,	  J	  =	  5.8),	  124.2	  (q,	  J	  =	  
274),	   118.0,	   53.9,	   51.0,	   38.3.	   HRMS	   (ESI)	   m/z:	   [M+Na]+	  
Calculated	  for	  C20H15F6NNaO2	  438.0900;	  Found:	  438.0883 
Methyl	   2-­‐cyano-­‐3-­‐[4-­‐(trifluoromethyl)phenyl]-­‐2-­‐{[4-­‐
(trifluoromethyl)phenyl]	   methyl}propionate	   (3g).	   Methyl	  
cyanoacetate	  2	  (11.37	  mmol	  1.00	  mL),	  DBU	  (23.88	  mmol,	  3.57	  
mL)	  and	  4-­‐(trifluoromethyl)benzyl	  bromide	   (22.85	  mmol,	  5.46	  
g)	  gave	  the	  title	  compound	  (3.75	  g,	  80%)	  as	  white	  crystals.	  1H	  
NMR	  (400	  MHz,	  CDCl3):	  δ	  7.61	  (d,	  J	  =	  8.2,	  4H),	  7.43	  (d,	  J	  =	  8.1,	  
4H),	   3.57	   (s,	   3H),	   3.41	   (dAB,	   J	   =	   13.4,	   2H),	   3.17	   (dAB,	   J	   =	   13.4,	  
2H).	   13C	  NMR	   (101	  MHz,	   CDCl3):	   δ	   168.2,	   137.8,	   130.6	   (q,	   J	   =	  
33.3),	  130.5,	  125.8	  (q,	  J	  =	  3.8),	  124.1	  (q,	  J	  =	  272.7),	  117.9,	  53.6,	  
52.9,	   43.0.	   HRMS	   (ESI)	   m/z:	   [M+Na]+	   Calculated	   for	  
C20H15F6NNaO2	  438.0900;	  Found:	  438.0882	  
Methyl	   3-­‐[3,5-­‐bis(trifluoromethyl)phenyl]-­‐2-­‐{[3,5-­‐
bis(trifluoromethyl)phenyl]methyl}-­‐2-­‐cyanopropionate	   (3h).	  
Methyl	  cyanoacetate	  2	  (5.46	  mmol,	  0.48	  mL),	  DBU	  (11.4	  mmol,	  
1.71	   mL)	   and	   3,5-­‐di(trifluoromethyl)benzyl	   bromide	   (10.9	  
mmol,	  2.0	  mL)	  gave	  the	  title	  compound	  (2.98	  g,	  99%)	  as	  white	  
crystals.	  1H	  NMR	  (400	  MHz,	  CDCl3):	  δ	  7.88	  (s,	  2H),	  7.75	  (s,	  4H),	  
3.60	  (s,	  3H),	  3.53	  (dAB,	  J	  =	  13.6,	  2H),	  3.25	  (dAB,	  J	  =	  13.6,	  2H).	  
13C	  NMR	  (101	  MHz,	  CDCl3):	  δ	  167.8,	  136.0,	  132.4	  (q,	  J	  =	  33.6),	  
130.3,	  123.1	  (q,	  J	  =	  274.3),	  122.6	  (p,	  J	  =	  3.8),	  116.8,	  54.0,	  52.8,	  
42.7.	   HRMS	   (ESI)	   m/z:	   [M+Na]+	   Calculated	   for	  
C22H13F12NNaO	  574.0648;	  Found:	  574.0631	  
Methyl	   2-­‐cyano-­‐3-­‐[4-­‐(tert-­‐butyl)phenyl]-­‐2-­‐{[4-­‐(tert-­‐
butyl)phenyl]methyl}propionate	   (3i).	  Methyl	   cyanoacetate	   2	  
(37.34	   mmol,	   3.3	   mL),	   DBU	   (77.51	   mmol,	   11.8	   mL)	   and	   4-­‐
tertbutylbenzyl	   bromide	   (77.51	  mmol,	   17.65	   g)	   gave	   the	   title	  
compound	  (13.92	  g,	  95%)	  as	  white	  crystals.	  1H	  NMR	  (400	  MHz,	  
CDCl3):	  δ	  7.34	  (d,	  J	  =	  8.3,	  4H),	  7.22	  (d,	  J	  =	  8.2,	  4H),	  3.56	  (s,	  3H),	  
3.28	   (dAB,	   J	  =	  13.6,	  2H),	  3.08	   (dAB,	   J	  =	  13.6,	  2H),	  1.31	   (s,	  18H).	  
13C	  NMR	  (101	  MHz,	  CDCl3):	  δ	  169.0,	  150.9,	  131.1,	  129.8,	  125.7,	  
118.9,	   53.5,	   53.2,	   42.9,	   34.7,	   31.5.	   HRMS	   (ESI)	   m/z:	   [M+H]+	  
Calculated	  for	  C26H34NO2	  392.2584;	  Found:	  392.2584 
Methyl	   2-­‐cyano-­‐3-­‐(2-­‐naphthyl)-­‐2-­‐[(2-­‐
naphthyl)methyl]propionate	   (3j).	   Methyl	   cyanoacetate	   2	  
(50.46	   mmol,	   4.4	   mL),	   DBU	   (105.8	   mmol,	   15.8	   mL)	   and	   2-­‐
(bromomethyl)naphtalene	  (105.8	  mmol,	  23.40	  g)	  gave	  the	  title	  
compound	   (18.24	   g,	   95%)	   as	   slightly	   brown	   crystals.	   1H	  NMR	  
(400	  MHz,	  CDCl3):	  δ	  7.87	   (m,	  8H),	  7.52	   (m,	  6H),	  3.58	   (dAB,	   J	  =	  
13.5,	  2H),	  3.55	   (s,	  3H),	  3.35	   (dAB,	   J	   =	  13.5,	  2H).	  
13C	  NMR	   (101	  
MHz,	  CDCl3):	  δ	  168.9,	  133.4,	  132.9,	  131.6,	  129.2,	  128.4,	  128.0,	  
127.8,	  127.7,	  126.4,	  126.3,	  118.6,	  53.5,	  53.2,	  43.5.	  HRMS	  (ESI)	  
m/z:	   [M+H]+	   Calculated	   for	   C26H22NO2	   380.1644;	   Found:	  
380.1645	  
General	  procedure	  for	  aminolysis	  of	  3a-­‐j	  
The	   procedure	   was	   performed	   under	   N2.	   The	   alkylated	  
methylcyanoacetate	   (3a-­‐j)	   was	   added	   ethylenediamine	   and	  
stirred	   at	   room	   temperature	   until	   completion.	   The	   reaction	  
was	  monitored	  on	  TLC.	  After	  completion,	  the	  reaction	  mixture	  
was	   cooled	   on	   ice	   and	   water	   was	   added	   to	   the	   reaction	  
mixture	  until	  precipitation	  occurred.	  The	  product	  was	   filtered	  
off,	  washed	  carefully	  with	  water	  and	  dried	  under	  vacuum.	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3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(o-­‐bromophenyl)methyl]-­‐3-­‐
oxopropiononitrile	   (4a).	   3a	   (5.03	   mmol,	   2.20	   g)	   and	  
ethylenediamine	  (20	  mL)	  (2	  h)	  gave	  the	  title	  compound	  (2.31	  g,	  
97%)	   as	   white	   powder.	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
7.62	  (d,	  J	  =	  8.1,	  1.3,	  2H),	  7.43	  (dd,	  J	  =	  7.7,	  1.7,	  2H),	  7.34	  (td,	  J	  =	  
7.5,	  1.3,	  2H),	  7.21	  (td,	  J	  =	  7.7,	  1.8,	  2H),	  3.58	  (dAB,	  J	  =	  14.0,	  2H),	  
3.55	  (dAB,	  J	  =	  14.0,	  2H),	  3.48	  (t,	  J	  =	  6.7,	  2H),	  2.99	  (t,	  J	  =	  6.7,	  2H).	  
13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  169.8,	  135.9,	  134.4,	  132.8,	  
130.7,	   128.8,	   127.0,	   119.5,	   53.0,	   41.7,	   40.0,	   39.1.	  HRMS	   (ESI)	  
m/z:	   [M+H]+	   Calculated	   for	   C19H20
79Br2N3O	   463.9966;	   Found:	  
463.9953	  	  
3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(3,5-­‐
dibromophenyl)methyl]-­‐3-­‐oxopropiononitrile	   (4b).	   3b	   (8.23	  
mmol,	   4.890	   g)	   and	   ethylenediamine	   (50	  mL)	   (1	   h)	   gave	   the	  
title	   compound	   (4.80	   g,	   94%)	   as	  white	  powder.	   1H	  NMR	   (400	  
MHz,	  CDCl3):	  δ	  7.66-­‐7.61	  (m,	  2H),	  7.38	  (d,	  J	  =	  1.7,	  4H),	  6.42	  (s,	  
1H),	  3.35	  (d,	  J	  =	  13.3,	  2H),	  3.17	  (q,	  J	  =	  5.8,	  2H),	  2.89	  (d,	  J	  =	  13.3,	  
2H),	  2.65	  (t,	  J	  =	  6.0,	  2H),	  0.88	  (broad	  s,	  1H).	  13C	  NMR	  (101	  MHz,	  
CDCl3):	   δ	   165.3,	   138.1,	   133.9,	   131.9,	   123.2,	   119.0,	   53.2,	   42.9,	  
42.0,	   40.6.	   HRMS	   (ESI)	   m/z:	   [M+H]+	   Calculated	   for	  
C19H18
79Br4N3O	  619.8176;	  Found:	  619.8186	  
3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(2-­‐fluorophenyl)methyl]-­‐3-­‐
oxopropiononitrile	   (4c).	   3c	   (4.08	   mmol,	   1.284	   g)	   and	  
ethylenediamine	  (10	  mL)	  (5	  h)	  gave	  the	  title	  compound	  (1.28	  g,	  
92%)	   as	   white	   powder.	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
7.38-­‐7.30	   (m,	  4H),	   7.16-­‐7.09	   (m,	  4H),	   3.40	   (dAB,	   J	   =	   13.6,	   2H),	  
3.32	  (dAB,	  J	  =	  13.3,	  2H),	  3.15	  (t,	  J	  =	  6.5,	  2H),	  2.56	  (t,	  J	  =	  6.4,	  2H).	  
13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  168.7,	  162.7	  (d,	  J	  =	  242.4),	  
133.2	  (d,	  J	  =	  3.7),	  131.0	  (d,	  J	  =	  8.3),	  125.3	  (d,	  J	  =	  3.6),	  123.3	  (d,	  J	  
=	  15.4),	  119.8,	  116.5	  (d,	  J	  =	  22.7),	  53.5,	  43.9,	  41.4,	  36.4.	  HRMS	  
(ESI)	  m/z:	  [M+H]+	  Calculated	  for	  C19H20F2N3O	  344.1569;	  Found:	  
344.	  1555	  
3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(2,6-­‐difluorophenyl)methyl]-­‐
3-­‐oxopropiononitrile	   (4d).	   3d	   (8.21	   mmol,	   2.88	   g)	   and	  
ethylenediamine	  (10	  mL)	  (3	  h)	  gave	  the	  title	  compound	  (2.98	  g,	  
96%)	   as	   white	   powder.	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
7.42-­‐7.35	  (m,	  2H),	  7.01	  (t,	  J	  =	  8.1,	  4H),	  3.48	  (dAB,	  J	  =	  14.1,	  2H),	  
3.37	  (dAB,	  J	  =	  14.1,	  2H),	  3.23	  (t,	  J	  =	  6.5Hz,	  2H),	  2.68	  (t,	  J	  =	  6.5,	  
2H).	   13C	  NMR	   (101	  MHz,	  Methanol-­‐d4):	   δ	   168.7,	   163.2	   (d,	   J	   =	  
250),	   131.6	   (t,	   J	   =	   10.1),	   118.9,	   112.6-­‐112.4	   (m),	   112.2,	   52.1,	  
44.2,	   41.5,	   30.8.	   HRMS	   (ESI)	   m/z:	   [M+H]+	   Calculated	   for	  
C19H22F4N3O	  384.1693;	  Found:	  384.1694	   
3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(3,5-­‐difluorophenyl)methyl]-­‐
3-­‐oxopropiononitrile	   (4e).	   3e	   (4.29	   mmol,	   1.507	   g)	   and	  
ethylenediamine	  (25	  mL)	  (0.5	  h)	  gave	  the	  title	  compound	  (1.60	  
g,	  98%)	  as	  white	  powder.	  1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  
6.96-­‐6.85	   (m,	  6H),	  3.40	   (dAB,	   J	  =	  13.3,	  2H),	  3.15	   (dAB,	   J	  =	  13.4,	  
2H),	   3.11	   (t,	   J	   =	   6.8,	   2H),	   2.51	   (t,	   J	   =	   6.7,	   2H).	   13C	   NMR	   (101	  
MHz,	  Methanol-­‐d4):	  δ	  167.9,	  164.2	  (dd,	  J	  =	  247.6,	  12.9),	  140.3	  
(t,	   J	  =	  9.4),	  119.9,	  117.7	  –	  112.1	   (m),	  104.1	   (t,	   J	  =	  25.6),	  54.3,	  
43.4,	   43.3,	   41.4.	   HRMS	   (ESI)	   m/z:	   [M+H]+	   Calculated	   for	  
C19H18F4N3O	  380.1381;	  Found:	  380.1363	  
3-­‐(2-­‐Aminoethylamino)-­‐3-­‐oxo-­‐2,2-­‐bis{[2-­‐
(trifluoromethyl)phenyl]methyl}propiononitrile	  (4f).	  3f	  (0.539	  
mmol,	  0.224	  g)	  and	  ethylenediamine	  (3	  mL)	  (6h)	  gave	  the	  title	  
compound	  (0.18	  g,	  76%)	  as	  white	  powder.	  1H	  NMR	  (400	  MHz,	  
Methanol-­‐d4):	   δ	   7.73	   (d,	   J	   =	   7.9,	   2H),	   7.67-­‐7.46	   (m,	   6H),	   3.66	  
(dAB,	  J	  =	  14.6,	  2H),	  3.56	  (,	  t,	  J	  =	  6.8,	  2H),	  3.35	  (dAB,	  J	  =	  14.6,	  2H),	  
3.05	  (t,	  J	  =	  6.8,	  2H).	  13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  170.4,	  
134.8,	  133.3,	  132.7,	  130.7	  (q,	  J	  =	  29.3),	  129.4,	  127.6	  (q,	  J	  =	  5.8),	  
125.6	   (q,	   J	   =	  274.7),	   119.5,	   53.1,	   39.8,	   39.2,	   39.0.	  HRMS	   (ESI)	  
m/z:	   [M+H]+	   Calculated	   for	   C21H20F6N3O	   444.1506;	   Found:	  
444.1505	   
3-­‐(2-­‐Aminoethylamino)-­‐3-­‐oxo-­‐2,2-­‐bis{[4-­‐
(trifluoromethyl)phenyl]methyl}propiononitrile	   (4g).	  3g	   (0.78	  
mmol,	  0.325	  g)	  and	  ethylenediamine	  (5	  mL)	  (2	  h)	  gave	  the	  title	  
compound	  (0.293	  g,	  85%)	  as	  white	  powder.	  1H	  NMR	  (400	  MHz,	  
Methanol-­‐d4):	  δ	  7.64	  (d,	  J	  =	  8.1,	  4H),	  7.52	  (d,	  J	  =	  8.1,	  4H),	  3.51	  
(dAB,	  J	  =	  13.3,	  2H),	  3.24	  (dAB,	  J	  =	  13.3,	  2H),	  3.05	  (t,	  J	  =	  6.6,	  2H),	  
2.46	  (t,	  J	  =	  6.6,	  2H).	  13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  161.1,	  
140.8	  (d,	  J	  =	  1.4),	  132.0,	  131.0	  (q,	  J	  =	  32.4),	  126.4	  (q,	  J	  =	  3.8),	  
125.6	   (q,	   J	   =	   272.7),	   119.9,	   54.6,	   43.7,	   43.6,	   41.3.	  HRMS	   (ESI)	  




(4h).	  3h	  (2.70	  mmol,	  0.95	  g)	  and	  ethylenediamine	  (10	  mL)	  (1	  h)	  
gave	   the	   title	   compound	   (0.87	   g,	   92%)	   as	   white	   powder.	   1H	  
NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  7.94	  (s,	  2H),	  7.92	  (s,	  4H),	  3.65	  
(dAB,	  J	  =	  13.4,	  2H),	  3.41	  (dAB,	  J	  =	  13.4,	  2H),	  3.03	  (t,	  J	  =	  6.9,	  2H),	  
2.42	  (t,	  J	  =	  6.9,	  2H).	  13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  167.5,	  
139.4,	   132.8	   (q,	   J	   =	   33.3),	   131.8,	   124.7	   (q,	   J	   =	   272.9),	   122.8-­‐
122.7	   (m),	   119.3,	   54.6,	   43.4,	   43.0,	   41.4.	   HRMS	   (ESI)	   m/z:	  
[M+H]+	   Calculated	   for	   C23H18F12N3O
+	   580.1260;	   Found:	  
580.1253	  
3-­‐(2-­‐Aminoethylamino)-­‐3-­‐oxo-­‐2,2-­‐bis{[4-­‐(tert-­‐
butyl)phenyl]methyl}propiononitrile	   (4i).	   3i	   (25.21	   mmol,	  
9.857	   g)	   and	   ethylenediamine	   (100	  mL)	   (24	   h)	   gave	   the	   title	  
compound	  (7.61	  g,	  72%)	  as	  white	  powder.	  1H	  NMR	  (400	  MHz,	  
Methanol-­‐d4):	  δ	  7.35	  (d,	  J	  =	  8.2,	  4H),	  7.24	  (d,	  J	  =	  8.2,	  4H),	  3.34	  
(ABd,	  J	  =	  13.4,	  2H),	  3.07-­‐3.04	  (m,	  4H),	  2.47	  (t,	  J	  =	  6.3,	  2H),	  1.30	  
(s,	   18H).	   13C	   NMR	   (101	   MHz,	   Methanol-­‐d4):	   δ	   169.1,	   151.7,	  
133.4,	  130.9,	  126.3,	  120.7,	  55.4,	  43.8,	  43.7,	  35.3,	  31.7.	  HRMS	  
(ESI)	  m/z:	   [M+H]+	  Calculated	   for	  C27H38N3O
+	  420.3015;	  Found:	  
420.3009	  
3-­‐(2-­‐Aminoethylamino)-­‐2,2-­‐bis[(2-­‐naphthyl)methyl]-­‐3-­‐
oxopropiononitrile	   (4j).	   3j	   (62.20	   mmol,	   23.57	   g)	   and	  
ethylenediamine	   (100	   mL)	   (24	   h)	   gave	   the	   title	   compound	  
(20.75	  g,	  82%)	  as	  white	  powder.	  1H	  NMR	  (400	  MHz,	  Methanol-­‐
d4):	  δ	  7.82-­‐7.78	  (m,	  8H),	  7.49-­‐7.43	  (m,	  6H),	  3.60	  (dAB,	  J	  =	  13.4,	  
2H),	  3.30	  (dAB,	  J	  =	  13.4,	  2H),	  2.99	  (t,	  J	  =	  6.4,	  2H),	  2.35	  (t,	  J	  =	  6.4,	  
2H).	   13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  168.3,	  134.7,	  134.2,	  
133.8,	   130.2,	   129.0,	   129.0,	   128.8,	   128.6,	   127.3,	   127.1,	   120.7,	  
55.5,	   44.3,	   43.6,	   41.2.	  HRMS	   (ESI)	  m/z:	   [M+H]+	  Calculated	   for	  
C27H26N3O
+	  408.2075;	  Found:	  408.2080	  
General	  procedure	  for	  reduction	  with	  Raney	  Nickel	  at	  8	  bar	  
(Method	  A)	  
One	  spoon	  of	  Raney	  Nickel	  (approx.	  5	  g)	  was	  transferred	  to	  the	  
50	   mL	   Parr	   hydrogenation	   bomb,	   washed	   with	   3	   x	   15	   mL	  
MeOH	  before	  addition	  of	  substrate	  (0.2-­‐2.5	  mmol)	  and	  Boc2O	  
(approx.	  4	  eq.).	  The	  reaction	  was	  stirred	  overnight	  (18	  h)	  at	  45	  
°C	  at	  8-­‐10	  bar.	  After	  completion,	  the	  bomb	  was	  cooled	  to	  room	  
temperature,	  the	  reaction	  mixture	  was	  purged	  and	  the	  catalyst	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was	  filtered	  off	  through	  a	  pad	  of	  sand	  and	  celite	  under	  N2	  and	  
the	  filtrate	  evaporated	  to	  dryness.	  The	  crude	  was	  dissolved	  in	  
dioxane	  and	  added	  4M	  HCl/dioxane	  and	  H2O	  and	  heated	  to	  60	  
°C	  for	  2	  h.	  The	  reaction	  mixture	  was	  evaporated	  to	  dryness	  and	  
purified	  on	  C18	  RP	   flash	   chromatography	   (acetonitrile/water)	  
or	  dissolved	  in	  EtOAc	  and	  precipitated	  by	  addition	  of	  Et2O.	  	  
Warning:	   Reactions	   at	   larger	   scale	   (12	   mmol)	   are	   not	  
recommended	  in	  the	  50	  mL	  Parr	  bomb.	  Delayed,	  uncontrolled	  
gas	   evolution	   after	   the	   release	   of	   hydrogen	   pressure	   was	  
observed.	  
General	  procedure	  for	  reduction	  with	  Raney	  Nickel	  at	  1	  bar	  
(Method	  B)	  
One	  spoon	  of	  Raney	  Nickel	   (approx.	  5	  g)	  was	  transferred	  to	  a	  
round	  bottom	  flask,	  washed	  with	  3	  x	  15	  mL	  MeOH	  and	  3	  x	  15	  
mL	  EtOAc	  before	  addition	  of	  substrate	  dissolved	  in	  EtOAc.	  The	  
reaction	  was	  stirred	  for	  48	  h	  (unless	  otherwise	  stated)	  at	  45	  °C	  
with	   a	   H2	   containing	   balloon	   attached.	   The	   reaction	   mixture	  
was	   cooled	   to	   room	   temperature	   before	   the	   catalyst	   was	  
filtered	  off	  through	  a	  pad	  of	  sand	  and	  celite	  under	  N2,	  washed	  
with	  brine,	  dried	  with	  Na2SO4	  and	  evaporated	  to	  dryness.	  The	  
product	   was	   purified	   by	   C18	   RP	   flash	   chromatography	  
(acetonitrile/water).	  	  
General	  procedure	  for	  reduction	  with	  ZnCl2/NaBH4	  (Method	  C)	  
The	  reducing	  agent	  was	  prepared	  by	  stirring	  ZnCl2	  (1	  eq.,	  1.15	  
g)	  and	  NaBH4	  (2	  eq.,	  0.68	  g)	  in	  dry	  THF	  (40	  mL)	  overnight.	  The	  
substrate	   (1	   eq.)	   was	   dissolved	   in	   the	   reducing	   agent	   (2	   eq.)	  
and	   refluxed	   for	   1.5	   h.	   The	   reaction	  mixture	   was	   allowed	   to	  
cool	  down	   to	  RT,	  quenched	  with	  0.1	  mL	  water	   followed	  by	  1	  
mL	  6M	  aqueous	  HCl.	  The	  reaction	  mixture	  was	  refluxed	  for	  10	  
min	   until	   the	   boron-­‐compound-­‐complex	   had	   dissociated	  
(followed	  by	  MS).	  The	  reaction	  mixture	  evaporated	  to	  dryness,	  




2-­‐[(2-­‐bromophenyl)methyl]-­‐1-­‐propanone	   (1a).	   4a	   was	  
reduced	   according	   to	  method	   C.	   4a	   (1.01	  mmol,	   0.51	   g)	   and	  
the	   reducing	  agent	   (7.0	  mL)	  gave	   the	   title	  compound	  as	  clear	  
crystals	   after	   purification	   (0.45	   g,	   75%).	   1H	   NMR	   (400	   MHz,	  
Methanol-­‐d4)	  δ	  7.63	  (d,	  J	  =	  8.0,	  2H),	  7.37	  –	  7.36	  (m,	  4H),	  7.23	  –	  
7.19	  (m,	  2H),	  3.61	  (t,	  J	  =	  6.2,	  2H),	  3.49	  (dAB,	  J	  =	  14.7,	  2H),	  3.44	  
(dAB,	   J	  =	  14.8,	  2H),	  3.19	   (t,	   J	   =	  6.3,	  4H),	  3.13	   (s,	  2H).	  
13C	  NMR	  
(101	   MHz,	   Methanol-­‐d4)	   176.3,	   136.2,	   134.5,	   133.4,	   130.4,	  
128.9,	   127.1,	   51.6,	   43.4,	   40.6,	   40.5,	   39.0.	   HRMS	   (ESI)	   m/z:	  
[M+H]+	   Calculated	   for	   C19H24




propanone	   (1b).	   4b	  was	   reduced	   according	   to	  method	   C.	  4b	  
(1.01	  mmol,	  0.66	  g)	  and	  the	  reducing	  agent	  (7.1	  mL)	  gave	  the	  
title	   compound	   as	   clear	   crystals	   after	   purification	   (0.54	   g,	   80	  
%).	   1H	   NMR	   (400	  MHz,	  Methanol-­‐d4):	   δ	   7.68	   (s,	   2H),	   7.48	   (s,	  
4H),	  3.54	  (t,	  J	  =	  6.3,	  2H),	  3.27	  (dAB,	  J	  =	  14.1,	  2H),	  3.15	  (t,	  J	  =	  6.4,	  
2H)	   3.04	   (s,	   2H),	   3.01	   (dAB,	   J	   =	   14.3,	   2H).	  
13C	  NMR	   (101	  MHz,	  
Methanol-­‐d4):	   δ	  175.4,	   140.9,	   134.1,	   133.5,	   124.0,	   50.6,	   43.3,	  
40.7,	   40.0,	   38.5.	   HRMS	   (ESI)	   m/z:	   [M+H]+	   Calculated	   for	  
C19H22
79Br4N3O	  623.8491;	  Found:	  623.8496	  
2-­‐fluorophenyl)-­‐2-­‐[(2-­‐fluorophenyl)methyl]-­‐1-­‐propanone	  
(1c).	   4c	  was	   reduced	   according	   to	  method	  A.	  4c	   (0.57	  mmol,	  
0.20	  g),	  Boc2O	  (2.3	  mmol,	  0.51	  g)	  and	  1	  spoon	  of	  Raney	  Nickel	  
in	   MeOH	   gave	   the	   di-­‐Boc-­‐protected	   intermediate.	   The	  
intermediate	  was	  added	  4	  mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  
4M	  HCl/dioxane	  to	  yield	  the	  crude,	  which	  was	  purified	  by	  C18	  
RP	   flash	  chromatography	  to	  yield	   the	  title	  compound	  as	  clear	  
crystals	   (0.053	   g,	   25%).	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
7.38	  –	  7.33	   (m,	  4H),	  7.21	  –	  7.10	   (m,	  4H),	  3.56	   (t,	   J	  =	  6.2,	  2H),	  
3.43	  (dAB,	  J	  =	  14.4,	  2H),	  3.16	  (t,	  J	  =	  6.2,	  2H),	  3.09	  (dAB,	  J	  =	  14.4,	  
2H)	   2.95	   (s,	   2H).	   13C	   NMR	   (101	  MHz,	  Methanol-­‐d4):	   δ	   176.0,	  
162.8	  (d,	  J	  =	  243.0),	  134.1	  (d,	  J	  =	  4.1),	  130.9	  (d,	  J	  =	  8.6),	  125.7	  
(d,	   J	  =	  3.5),	  123.4	   (d,	   J	  =	  15.7),	  116.6	   (d,	   J	  =	  23.2),	  51.2,	  42.9,	  
40.7,	   38.8,	   34.4.	   HRMS	   (ESI)	   m/z:	   [M+H]+	   Calculated	   for	  
C19H24F2N3O	  348.1887;	  Found:	  348.1890	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐(2,6-­‐
difluorophenyl)-­‐2-­‐[(2,6-­‐difluorophenyl)methyl]-­‐1-­‐propanone	  
(1d).	  4d	  was	  reduced	  according	  to	  method	  A.	  4d	   (0.65	  mmol,	  
0.25	  g),	  Boc2O	  (2.84	  mmol,	  0.61	  g)	  and	  1	  spoon	  of	  Raney	  Nickel	  
in	   MeOH	   gave	   the	   di-­‐Boc-­‐protected	   intermediate.	   The	  
intermediate	  was	  added	  4	  mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  
4M	   HCl/dioxane	   to	   yield	   the	   crude,	   which	   was	   dissolved	   in	  
EtOAc	  and	  precipitated	   in	  Et2O	  to	  yield	  the	  title	  compound	  as	  
white	  crystals	  (0.22	  g,	  90%).	  1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  
δ	  7.41	  (tt,	  J	  =	  8.3,	  6.6,	  2H),	  7.06	  (t*,	  J	  =	  8.2,,	  4H),	  3.57	  (t,	  J	  =	  6.0,	  
2H),	  3.48	  (dAB,	  J	  =	  14.5,	  2H),	  3.18	  (t,	  J	  =	  6.0,	  2H),	  3.13	  (dAB,	  J	  =	  
14.5,	   2H),	   2.90	   (s,	   2H).	   *broadened	   by	   19F	   splitting.	   13C	   NMR	  
(101	  MHz,	  Methanol-­‐d4):	   δ	   175.0,	   163.2	   (dd,	   J	   =	   245.7,	   8.1),	  
131.4	   (t,	   J	   =	   10.7),	   113.0-­‐112.6	   (m),	   112.3	   (t,	   J	   =	   20.2),	   51.5,	  
42.2,	   40.8,	   39.1,	   28.3.	  HRMS	   (ESI)	  m/z:	   [M+H]+	  Calculated	   for	  
C19H22F4N3O	  384.1699;	  Found:	  384.1694	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐(3,5-­‐
difluorophenyl)-­‐2-­‐[(3,5-­‐difluorophenyl)methyl]-­‐1-­‐propanone	  
(1e).	  4e	  was	   reduced	  according	   to	  method	  A.	  4e	   (0.54	  mmol,	  
0.20	  g),	  Boc2O	  (2.30	  mmol,	  0.50	  g)	  and	  1	  spoon	  of	  Raney	  Nickel	  
in	   MeOH	   gave	   the	   di-­‐Boc-­‐protected	   intermediate.	   The	  
intermediate	  was	  added	  4	  mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  
4M	  HCl/dioxane	  to	  yield	  the	  crude,	  which	  was	  purified	  by	  C18	  
RP	   flash	  chromatography	  to	  yield	   the	  title	  compound	  as	  clear	  
crystals	   (0.074	   g,	   36%).	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
6.97-­‐6.87	  (m,	  6H),	  3.55	  (t,	  J	  =	  6.2,	  2H),	  3.39	  (dAB,	  J	  =	  14.1,	  2H),	  
3.15	   (t,	   J	   =	   6.2,	   2H),	   3.05	   (dAB,	   J	   =	   14.1,	   2H),	   3.06	   (s,	   2H).	  
13C	  
NMR	   (101	  MHz,	  Methanol-­‐d4):	   δ	   175.7,	   164.4	   (dd,	   J	   =	   247.7,	  
13.1),	  140.8	   (t,	   J	  =	  9.2),	  117.9	  –	  112.1	   (m),	  103.8	   (t,	   J	  =	  25.7),	  
50.7,	  43.0,	  40.6,	  40.5,	  38.5.	  HRMS	  (ESI)	  m/z:	  [M+H]+	  Calculated	  
for	  C19H22F4N3O	  384.1699;	  Found:	  384.1698	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐[2-­‐
(trifluoromethyl)phenyl]-­‐2-­‐{[2-­‐
(trifluoromethyl)phenyl]methyl}-­‐1-­‐propanone	   (1f).	   4f	   was	  
reduced	  according	  to	  method	  A	  and	  B.	  
Method	  A:	  4f	   (0.24	  mmol,	  0.11	  g),	  Boc2O	  (0.95	  mmol,	  0.20	  g)	  
and	   1	   spoon	   of	   Raney	   Nickel	   in	   MeOH	   gave	   the	   di-­‐Boc-­‐
protected	   intermediate.	   The	   intermediate	   was	   added	   4	   mL	  
dioxane,	   0.5	   mL	   H2O	   and	   2	   mL	   4M	   HCl/dioxane	   to	   yield	   the	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crude,	  which	  was	  purified	  by	  C18	  RP	  flash	  chromatography	  to	  
yield	  the	  title	  compound	  as	  clear	  crystals	  (0.053	  g,	  50%).	  
Method	  B:	  4f	   (0.50	  mmol,	   0.22	   g),	   Boc2O	   (6	   eq.),	   ammonium	  
formate	  (4	  eq.)	  and	  1	  spoon	  of	  Raney	  Nickel	  in	  EtOAc	  gave	  the	  
di-­‐Boc-­‐protected	  intermediate.	  The	  intermediate	  was	  added	  4	  
mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  4M	  HCl/dioxane	  to	  yield	  the	  
crude,	  which	  was	  purified	  by	  C18	  RP	  flash	  chromatography	  to	  
yield	  the	  title	  compound	  (0.066	  g,	  30	  %).	  
	  1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  7.77	  (dd,	  J	  =	  7.9,	  1.4,	  2H),	  
7.64	  (td,	  J	  =	  7.7,	  1.4,	  2H),	  7.51	  (t,	  J	  =	  7.6,	  2H),	  7.40	  (d,	  J	  =	  7.8,	  
2H),	  3.54	  (t,	  J	  =	  6.9,	  2H),	  3.44	  (dAB,	  J	  =	  15.7,	  2H),	  3.37	  (dAB,	  J	  =	  
16.0,	   2H),	   3.03	   (s,	   2H).	   13C	   NMR	   (101	   MHz,	   Methanol-­‐d4):	   δ	  
177.3,	  134.8,	  133.4,	  132.7,	  130.8	  (q,	  J	  =	  29.4),	  129.1,	  128.1	  (q,	  J	  
=	  5.7),	  125.8	   (q,	   J	  =	  274.7),	  45.2,	  39.9,	  38.7,	  37.7.	  HRMS	   (ESI)	  




(trifluoromethyl)phenyl]methyl}-­‐1-­‐propanone	   (1g).	   4g	   was	  
reduced	  according	  to	  method	  A.	  4g	  (0.18	  mmol,	  0.08	  g),	  Boc2O	  
(0.72	  mmol,	  0.15	  g)	  and	  1	  spoon	  of	  Raney	  Nickel	  in	  MeOH	  gave	  
the	   di-­‐Boc-­‐protected	   intermediate.	   The	   intermediate	   was	  
added	  2	  mL	  dioxane,	  0.2	  mL	  H2O	  and	  1	  mL	  4M	  HCl/dioxane	  to	  
yield	   the	   crude,	   which	   was	   purified	   by	   C18	   reversed	   phase	  
flash	   chromatography	   to	   yield	   the	   title	   compound	   as	   clear	  
crystals	   (0.042	   g,	   53%).	   1H	   NMR	   (400	   MHz,	   Methanol-­‐d4):	   δ	  
7.65	  (d,	  J	  =	  7.7,	  4H),	  7.49	  (d,	  J	  =	  7.8,	  4H),	  3.54	  (t,	   J	  =	  6.0,	  2H),	  
3.45	   (dAB,	   J	  =	  14.0,	  2H),	  3.18-­‐3.13	   (m,	  2H),	  3.10	   (dAB,	   J	  =	  14.0,	  
2H),	   3.01	   (s,	   2H).	   13C	  NMR	   (101	  MHz,	  Methanol-­‐d4):	   δ	   176.0,	  
142.5	  –	  139.5	  (m),	  132.3,	  130.7	  (q,	  J	  =	  32.4),	  126.5	  (q,	  J	  =	  3.7),	  
125.6	   (q,	   J	   =	   272.2),	   50.7,	   43.1,	   40.7,	   38.7.	   HRMS	   (ESI)	   m/z:	  
[M+H]+	  Calculated	  for	  C21H24F6N3O	  448.1824;	  Found:	  448.1824	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐[3,5-­‐
bis(trifluoromethyl)phenyl]-­‐2-­‐{[3,5-­‐
bis(trifluoromethyl)phenyl]methyl}-­‐1-­‐propanone	  (1h).	  4h	  was	  
reduced	  according	  to	  method	  A	  and	  B.	  
Method	  A:	  	  4h	  (0.52	  mmol,	  0.30	  g),	  Boc2O	  (2.74	  mmol,	  0.60	  g)	  
and	   1	   spoon	   of	   Raney	   Nickel	   in	   MeOH	   gave	   the	   di-­‐Boc-­‐
protected	   intermediate.	   The	   intermediate	   was	   added	   4	   mL	  
dioxane,	   0.5	   mL	   H2O	   and	   2	   mL	   4M	   HCl/dioxane	   to	   yield	   the	  
crude,	  which	  was	  purified	  by	  C18	  RP	  flash	  chromatography	  to	  
yield	  the	  title	  compound	  as	  clear	  crystals	  (0.067	  g,	  23%).	  	  
Method	  B:	  4h	   (0.59	  mmol,	  0.35	  g),	  Boc2O	   (6	  eq.),	  ammonium	  
formate	  (4	  eq.)	  and	  1	  spoon	  of	  Raney	  Nickel	  in	  EtOAc	  gave	  the	  
di-­‐Boc-­‐protected	  intermediate.	  The	  intermediate	  was	  added	  4	  
mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  4M	  HCl/dioxane	  to	  yield	  the	  
crude	  (0.34	  g,	  97	  %).	  
1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  7.94	  (s,	  6H),	  3.58-­‐3.47	  (m,	  
4H),	  3.29	  (dAB,	  J	  =	  14.4,	  2H),	  3.15	  (t,	  J	  =	  6.2,	  2H),	  3.10	  (s,	  2H).	  
13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  175.2,	  139.7,	  132.9	  (q,	  J	  =	  
33.2),	  132.3	  –	  131.9	  (m),	  124.8	  (q,	  J	  =	  273.0),	  122.5	  (p,	  J	  =	  3.9),	  
50.6,	  43.4,	  40.6,	  40.1,	  38.5.	  HRMS	  (ESI)	  m/z:	  [M+H]+	  Calculated	  
for	  C23H22F12N3O	  584.1572;	  Found:	  584.1567.	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐[4-­‐(tert-­‐
butyl)phenyl]-­‐2-­‐{[4-­‐(tert-­‐butyl)phenyl]methyl}-­‐1-­‐propanone	  
(1i).	  4i	  was	  reduced	  according	  to	  method	  A	  and	  B.	  
Method	  A:	  4i	  (0.606	  mmol,	  0.254	  g),	  Boc2O	  (2.42	  mmol,	  0.53	  g)	  
and	   1	   spoon	   of	   Raney	   nickel	   in	   MeOH	   gave	   the	   di-­‐Boc-­‐
protected	   intermediate.	   The	   intermediate	   was	   added	   4	   mL	  
dioxane,	   0.5	   mL	   H2O	   and	   2	   mL	   4M	   HCl/dioxane	   to	   yield	   the	  
crude,	  which	  was	  purified	  by	  C18	  RP	  flash	  chromatography	  to	  
yield	  the	  title	  compound	  as	  clear	  crystals	  (0.092	  g,	  35%).	  	  
Method	  B:	  4i	   (1.27	  mmol,	   0.53	   g),	   Boc2O	   (2	   eq.),	   ammonium	  
formate	   (4	   eq.)	   and	   1	   spoon	   of	   Raney	   Nickel	   in	   EtOAc	   (24h)	  
gave	  the	  di-­‐Boc-­‐protected	  intermediate.	  The	  intermediate	  was	  
added	  4	  mL	  dioxane,	  0.5	  mL	  H2O	  and	  2	  mL	  4M	  HCl/dioxane	  to	  
yield	   the	   crude,	   which	   was	   purified	   by	   C18	   RP	   flash	  
chromatography	  to	  yield	  the	  title	  compound	  (0.14	  g,	  27%).	  
1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  7.39	   (d,	   J	  =	  8.3,	  4H),	  7.17	  
(d,	  J	  =	  8.3,	  4H),	  3.51	  (t,	  J	  =	  6.4,	  2H),	  3.22	  (A	  dAB,	  J	  =	  14.2,	  2H),	  
3.11	  (t,	  J	  =	  6.4,	  2H),	  3.00	  (s,	  2H),	  2.94	  (dAB,	  J	  =	  14.2,	  2H),	  1.31	  (s,	  
18H).13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  δ	  177.3,	  151.6,	  133.4,	  
131.2,	   126.6,	   50.5,	   43.6,	   40.7,	   40.6,	   38.6,	   35.3,	   31.7.	   HRMS	  
(ESI)	  m/z:	   [M+H]+	   Calculated	   for	   C27H42N3O	   424.3327;	   Found:	  
424.3320.	  
1-­‐(2-­‐Aminoethylamino)-­‐2-­‐(aminomethyl)-­‐3-­‐(2-­‐naphthyl)-­‐2-­‐
[(2-­‐naphthyl)methyl]-­‐1-­‐propanone	   (1j).	   4j	   was	   reduced	  
according	  to	  method	  B:	  4j	   (2.60	  mmol,	  1.06	  g),	  Boc2O	  (4	  eq.),	  
ammonium	   formate	   (4	   eq)	   and	   1	   spoon	   of	   Raney	   Nickel	   in	  
EtOAc	   gave	   the	   di-­‐Boc-­‐protected	   intermediate.	   The	   di-­‐Boc-­‐
protected	   intermediate	   was	   purified	   by	   silica	   flash	  
chromatography.	   The	   resulting	   compound	   was	   added	   4	   mL	  
dioxane,	   0.5	   mL	   H2O	   and	   2	   mL	   4M	   HCl/dioxane	   to	   yield	   the	  
crude	  (0.86	  g,	  80%).	  1H	  NMR	  (400	  MHz,	  Methanol-­‐d4):	  δ	  7.88-­‐
7.7.84	  (m,	  6H),	  7.75	  (s,	  2H),	  7.55-­‐7.45	  (m,	  4H),	  7.38	  (d,	  J	  =	  8.4,	  
2H),	  3.35	  (t,	  J	  =	  6.6,	  2H),	  3.42	  (dAB,	  J	  =	  14.0,	  2H),	  3.21	  (dAB,	  J	  =	  
14.2,	  2H),	  3.11-­‐3.08	  (m,	  4H).	  13C	  NMR	  (101	  MHz,	  Methanol-­‐d4):	  
δ	  177.1,	  134.8,	  134.1,	  133.9,	  130.4,	  129.3,	  129.3,	  128.7,	  128.7,	  
127.5,	   127.2,	   50.9,	   43.9,	   41.4,	   40.6,	   38.7.	   HRMS	   (ESI)	   m/z:	  
[M+H]+	  Calculated	  for	  C27H30N3O	  412.2388;	  Found:	  412.2382.	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